p.68 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

June 11, 2024 Circulation. 2024;149:e1313–e1410. DOI: 10.1161/CIR.0000000000001251 e1380

2.	 Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317– 1324. 3.	 Schorr EN, Treat-Jacobson D. Methods of symptom evaluation and their impact on peripheral artery disease (PAD) symptom prevalence: a review. Vasc Med. 2013;18:95–111. 4.	 Newman AB, Naydeck BL, Sutton-Tyrrell K, et al. The role of comorbidity in the assessment of intermittent claudication in older adults. J Clin Epidemiol. 2001;54:294–300. 5.	 McDermott MM, Greenland P, Liu K, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002;136:873–883. 6.	 McDermott MM, Guralnik JM, Ferrucci L, et al. Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation. 2008;117:2484–2491. 7.	 McDermott MM, Applegate WB, Bonds DE, et al. Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study. J Am Heart Assoc. 2013;2:e000257. 8.	 Lee JY, Lee SW, Lee WS, et al. Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease. J Am Coll Cardiol Intv. 2013;6:1303–1313. 9.	 Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120:2053–2061. 10.	 Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med. 1977;31:42– 48. 11.	 McDermott MM, Mehta S, Greenland P. Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med. 1999;159:387–392. 12.	 Ruger LJ, Irnich D, Abahji TN, et al. Characteristics of chronic ischemic pain in patients with peripheral arterial disease. Pain. 2008;139:201–208. 13.	 Tomczyk S, Treat-Jacobson D. Claudication symptom experience in men and women: is there a difference? J Vasc Nurs. 2009;27:92–97. 14.	 Schorr EN, Peden-McAlpine C, Treat-Jacobson D, et al. Characterization of the peripheral artery disease symptom experience. Geriatr Nurs. 2015;36:293–300. 15.	 Schorr EN, Treat-Jacobson D, Lindquist R. The relationship between peripheral artery disease symptomatology and ischemia. Nurs Res. 2017;66:378– 387. 16.	 Creager MA, Matsushita K, Arya S, et al. Reducing nontraumatic lowerextremity amputations by 20% by 2030: time to get to our feet: a policy statement from the American Heart Association. Circulation. 2021;143:e875–e891. 17.	 Criqui MH, Matsushita K, Aboyans V, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144:e171–e191. 18.	 Aboyans V, Sevestre MA, Desormais I, et al. [Epidemiology of lower extremity artery disease]. Presse Med. 2018;47:38–46. 19.	 Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59:220–234.e1-2. 20.	 Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1-S75. 21.	 Wubbeke LF, Kremers B, Daemen JHC, et al. Mortality in octogenarians with chronic limb threatening ischaemia after revascularisation or conservative therapy alone. Eur J Vasc Endovasc Surg. 2021;61:350–351. 22.	 Farber A, Menard MT, Conte MS, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387:2305–2316. 23.	 Fontaine R, Kim M, Kieny R. [Surgical treatment of peripheral circulation disorders]. Helv Chir Acta. 1954;21:499–533. 24.	 Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517–538. 25.	 Darling JD, McCallum JC, Soden PA, et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia. J Vasc Surg. 2016;64:616–622. 26.	 Cull DL, Manos G, Hartley MC, et al. An early validation of the Society for

Vascular Surgery lower extremity threatened limb classification system. J Vasc Surg. 2014;60:1535–1541. 27 Zhan LX, Branco BC, Armstrong DG, et al. The Society for Vascular Sur-

gery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing. J Vasc Surg. 2015;61:939–944. 28.	 Beropoulis E, Stavroulakis K, Schwindt A, et al. Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia. J Vasc Surg. 2016;64:95–103. 29.	 Hess CN, Huang Z, Patel MR, et al. Acute limb ischemia in peripheral artery disease. Circulation. 2019;140:556–565. 30.	 Creager MA, Belkin M, Bluth EI, et al. 2012 ACCF/AHA/ACR/SCAI/SIR/

STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). Circulation. 2012;125:395–467. 2.2. History and Physical Examination to Assess for PAD 1.	 McDermott MM, Mehta S, Greenland P. Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med. 1999;159:387–392. 2.	 Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317– 1324. 3.	 McDermott MM. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015;116:1540–1550. 4.	 McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286:1599–1606. 5.	 Khan NA, Rahim SA, Anand SS, et al. Does the clinical examination predict lower extremity peripheral arterial disease? JAMA. 2006;295:536–546. 6.	 Criqui MH, Denenberg JO, Bird CE, et al. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996;1:65–71. 7.	 Armstrong DW, Tobin C, Matangi MF. The accuracy of the physical examination for the detection of lower extremity peripheral arterial disease. Can J Cardiol. 2010;26:e346–350. 8.	 Cournot M, Boccalon H, Cambou JP, et al. Accuracy of the screening physical examination to identify subclinical atherosclerosis and peripheral arterial disease in asymptomatic subjects. J Vasc Surg. 2007;46:1215–1221. 9.	 Criqui MH, Matsushita K, Aboyans V, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144:e171–e191. 10.	 Allison MA, Cushman M, Solomon C, et al. Ethnicity and risk factors for change in the ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis. J Vasc Surg. 2009;50:1049–1056. 11.	 Wennberg PW. Approach to the patient with peripheral arterial disease. Circulation. 2013;128:2241–2250. 12.	 Londero LS, Lindholt JS, Thomsen MD, et al. Pulse palpation is an effective method for population-based screening to exclude peripheral arterial disease. J Vasc Surg. 2016;63:1305–1310. 13.	 Wassel CL, Loomba R, Ix JH, et al. Family history of peripheral artery disease is associated with prevalence and severity of peripheral artery disease: the San Diego population study. J Am Coll Cardiol. 2011;58:1386–1392. 14.	 Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e726–e779. 15.	 Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the

management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1-S75. 3.1. Resting ABI and Additional Physiological Testing 1.	 Lijmer JG, Hunink MG, van den Dungen JJ, et al. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol. 1996;22:391– 398. 2.	 Xu D, Zou L, Xing Y, et al. Diagnostic value of ankle-brachial index in peripheral arterial disease: a meta-analysis. Can J Cardiol. 2013;29:492–498. 3.	 Aboyans V, Criqui MH, Abraham P, et al. Measurement and interpretation

of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126:2890–2909.

Downloaded from http://ahajournals.org by on October 7, 2026